Evidence map›Paper›PMID 34949984›Full record

ArticleFrontiers in neuroscience2021

Acute Response and Neuroprotective Role of Myo/Nog Cells Assessed in a Rat Model of Focal Brain Injury.

Sahlia Joseph-Pauline, Nathan Morrison, Michael Braccia, Alana Payne, Lindsay Gugerty, Jesse Mostoller, Paul Lecker, E-Jine Tsai, Jessica Kim, Mark Martin and 7 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in neuroscience, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 2 institutions in 2 countries.

Sahlia Joseph-PaulinePhiladelphia College of Osteopathic Medicine, Philadelphia, PA, United States.
Nathan MorrisonPhiladelphia College of Osteopathic Medicine, Philadelphia, PA, United States.
Michael BracciaPhiladelphia College of Osteopathic Medicine, Philadelphia, PA, United States.
Alana PaynePhiladelphia College of Osteopathic Medicine, Philadelphia, PA, United States.
Lindsay GugertyPhiladelphia College of Osteopathic Medicine, Philadelphia, PA, United States.
Jesse MostollerPhiladelphia College of Osteopathic Medicine, Philadelphia, PA, United States.
Paul LeckerPhiladelphia College of Osteopathic Medicine, Philadelphia, PA, United States.
E-Jine TsaiPhiladelphia College of Osteopathic Medicine, Philadelphia, PA, United States.
Jessica KimPhiladelphia College of Osteopathic Medicine, Philadelphia, PA, United States.
Mark MartinPhiladelphia College of Osteopathic Medicine, Philadelphia, PA, United States.
Rushil BrahmbhattPhiladelphia College of Osteopathic Medicine, Philadelphia, PA, United States.
Grzegorz GorskiPhiladelphia College of Osteopathic Medicine, Philadelphia, PA, United States.
Jacquelyn GerhartPhiladelphia College of Osteopathic Medicine, Philadelphia, PA, United States.
Mindy George-WeinsteinPhiladelphia College of Osteopathic Medicine, Philadelphia, PA, United States.
Jonathan StoneSchool of Medical Sciences, University of Sydney, Sydney, NSW, Australia.
Sivaraman PurushothumanBrain and Mind Centre and Central Clinical School, University of Sydney, Sydney, NSW, Australia.
Arturo Bravo-NuevoPhiladelphia College of Osteopathic Medicine, Philadelphia, PA, United States.
Philadelphia College of Osteopathic Medicine · USUniversity of Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Focal brain injury in the form of a needlestick (NS) results in cell death and induces a self-protective response flanking the lesion. Myo/Nog cells are identified by their expression of bone morphogenetic protein inhibitor Noggin, brain-specific angiogenesis inhibitor 1 (BAI1) and the skeletal muscle specific transcription factor MyoD. Myo/Nog cells limit cell death in two forms of retinopathy. In this study, we examined the acute response of Myo/Nog cells to a NS lesion that extended from the rat posterior parietal cortex to the hippocampus. Myo/Nog cells were identified with antibodies to Noggin and BAI1. These cells were the primary source of both molecules in the uninjured and injured brain. One day after the NS, the normally small population of Myo/Nog cells expanded approximately eightfold within a 1 mm area surrounding the lesion. Myo/Nog cells were reduced by approximately 50% along the lesion with an injection of the BAI1 monoclonal antibody and complement. The number of dying cells, identified by terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling (TUNEL), was unchanged at this early time point in response to the decrease in Myo/Nog cells. However, increasing the number of Myo/Nog cells within the lesion by injecting BAI1-positive (+) cells isolated from the brains of other animals, significantly reduced cell death and increased the number of NeuN+ neurons compared to brains injected with phosphate buffered saline or exogenous BAI1-negative cells. These findings demonstrate that Myo/Nog cells rapidly react to injury within the brain and increasing their number within the lesion is neuroprotective.

Indexed as

BAI1focal brain injuryMyo/Nog cellsneuroprotectionrat brain

Identifiers

PMID34949984
PMCPMC8689062
OpenAlexW4200135738

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.